Health Law Diagnosed — Transactions Part 1: Regulatory Trends in Recent Health Care Transactions
2021 was a busy year for Mintz’s Health Law team, as they helped clients navigate complex health care transactions. Listen to hear the macro trends our team is seeing in the market, as well as their takeaways from the deals they closed.
Authors
Xavier G. Hardy
Associate
Xavier represents clients in the health care and life sciences fields on health care regulatory and fraud and abuse matters. He also handles Medicare and Medicaid reimbursement issues in transactions and business arrangements.
Bridgette A. Keller
Of Counsel
Bridgette advises health care providers, ACOs, health plans, PBMs, and laboratories on regulatory, fraud and abuse, and business planning matters, applying her experience in health system administration and ethics in health care to her health law practice.
Lauren M. Moldawer
Member
Lauren advises pharmacies, PBMs, managed care organizations, and other payors on transactional, regulatory, and fraud and abuse matters, drawing upon her experience working for the Federal Coordinated Health Care Office.
Cassandra L. Paolillo
Of Counsel
Cassandra L. Paolillo is Of Counsel at Mintz whose practice involves advising health care clients on transactional and regulatory matters, including mergers and acquisitions, regulatory compliance, and general contracting. Cassie primarily works with providers and payors.
Kate F. Stewart
Of Counsel
Kate F. Stewart is Of Counsel at Mintz and a former in-house counsel who focuses on legal issues affecting health care clients, including digital health and privacy regulations, clinical trial compliance, and transactions for for-profit and nonprofit clients. She represents traditional health care providers, payors, and digital health start-ups.